EPOL -0.46MRK 0.59CVE.TO -0.13ELF.TO -0.01JCI 0.53TEVA 0.93ESLOY 0MSFT -0.26
GlaxoSmithKline PLC (GSK)

NYSE:GSK

GlaxoSmithKline PLC (GSK)

49.35
-0.35 (0.70%)
as of Sep 29, 2026, 8:00:00 pm Market Open.
82 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
TOP PICK

GlaxoSmithKline PLC(GSK)

Jan 28, 2002
Good value. Yield of 2.3%. Good pipeline of products. Good R & D budget.
Photo of Arthur HeinmaaArthur HeinmaaUnlock Rating
$48.18

Stock price when the opinion was issued

$49.35

As of Sep 29, 2026. Market Open.

biotechnologypharmaceutical
BUY

GlaxoSmithKline PLC(GSK)

Aug 07, 2001
Has a new drug, competing with Prozac. Also into biotechs, making good diversification.
Photo of Arthur HeinmaaArthur HeinmaaUnlock Rating
$55.84

Stock price when the opinion was issued

$49.35

As of Sep 29, 2026. Market Open.

biotechnologypharmaceutical
BUY

GlaxoSmithKline PLC(GSK)

Jun 26, 2001
Good merger. A safe holding.
Photo of Gavin GrahamGavin GrahamUnlock Rating
$55.39

Stock price when the opinion was issued

$49.35

As of Sep 29, 2026. Market Open.

biotechnologypharmaceutical
PAST TOP PICK

GlaxoSmithKline PLC(GSK)

Mar 27, 2001
(Was a top pick on Oct 11 - Down 6%) but still likes it.
Photo of David DriscollDavid DriscollUnlock Rating
$53.15

Stock price when the opinion was issued

$49.35

As of Sep 29, 2026. Market Open.

biotechnologypharmaceutical
BUY

GlaxoSmithKline PLC(GSK)

Mar 27, 2001
Bullet proof portfolio-large caps (40%)
Photo of David DriscollDavid DriscollUnlock Rating
$53.15

Stock price when the opinion was issued

$49.35

As of Sep 29, 2026. Market Open.

biotechnologypharmaceutical
BUY

GlaxoSmithKline PLC(GSK)

Feb 14, 2001
A good merger making them the largest pharmaceutical
Photo of David DriscollDavid DriscollUnlock Rating
$55.31

Stock price when the opinion was issued

$49.35

As of Sep 29, 2026. Market Open.

biotechnologypharmaceutical
Showing 106 to 111 of 111 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

ZEO.TO -1.099$105.56
GEV 12.72$962.49
MX.TO -0.42$84.34
MSFT-NE 0$
TVE.TO -0.21$13.04
The ultimate 360° Tracker Your financial life in one place, automaticallywealthica-video

Today's Top Picks

EPOL -0.46$44.2
MRK 0.59$149.28
CVE.TO -0.13$43.99
ELF.TO -0.01$17.57
JCI 0.53$149.42

Popular Articles

Latest Sell Signals

BN.TO 0.32$51.7
EMA.TO 0.28$67.93
SIA.TO -0.232$20.19
CSH.UN.T… 0.002$20.37
ZLU.TO 0.14$62.1

Most Recent Experts

Colin Cieszynski

Colin Cieszynski

SIA Wealth Management

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Paul Harris, CFA

Paul Harris, CFA

Harris Douglas Asset Management

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Larry Berman CFA, CMT, CTA

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica

You may also like